Source: https://snpminertrials.s3.amazonaws.com/proteinmutation/clinicaltrial/NCT01967940.html
Timestamp: 2020-07-07 16:03:58
Document Index: 75281459

Matched Legal Cases: ['art 1', 'art 1', 'art 1', 'art 2', 'art 1', 'art 1', 'art 1', 'art 1']

Report for Clinical Trial NCT01967940
NCT01967940 HIV HIV Infections Acquired Immunodeficiency Syndrome
Description: 25 mg tablet administered orally once daily with food
Part 1 Sentinel Cohort (TAF) Part 1 Randomized Cohort (TAF)
Description: Tablets to match TAF administered orally once daily with food
Part 1 Randomized Cohort (Placebo)
Description: 150/150/200/10 mg STR administered orally once daily with food
Part 2 E/C/F/TAF+ATV
Name: Current failing ARV regimen
Description: Participants will continue taking their current ARV regimen as prescribed in Part 1.
Part 1 Sentinel Cohort (TAF) Part 1 Randomized Cohort (TAF) Part 1 Randomized Cohort (Placebo)
Description: 300 mg tablet administered orally once daily.